Company · CIK 2102720
Tarsier Pharma Ltd.
| CIK | 2102720 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | L3 |
| Listed | TARX |
| First annual or quarterly report | none on EDGAR |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-295210 | 2026-04-21 | 2026-07-16 | 6 |
Filings
7| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-07-16 | F-1/AAmendment | 333-295210 | 0001213900-26-078792 |
| 2026-07-15 | F-1/AAmendment | 333-295210 | 0001213900-26-078039 |
| 2026-06-16 | F-1/AAmendment | 333-295210 | 0001213900-26-069143 |
| 2026-06-08 | F-1/AAmendment | 333-295210 | 0001213900-26-066188 |
| 2026-05-18 | F-1/AAmendment | 333-295210 | 0001213900-26-058235 |
| 2026-04-21 | F-1Registration filed | 333-295210 | 0001213900-26-046063 |
| 2025-12-29 | DRSDraft made public | 377-08882 | 0001213900-25-125843 |